Medical Care
Global Oligonucleotide Contract Manufacturing Service Market Research Report 2025
- Jul 08, 25
- ID: 358826
- Pages: 92
- Figures: 97
- Views: 2
The global market for Oligonucleotide Contract Manufacturing Service was valued at US$ 1814 million in the year 2024 and is projected to reach a revised size of US$ 3773 million by 2031, growing at a CAGR of 11.2% during the forecast period.
Oligonucleotide Contract Manufacturing provides end-to-end services for the production of synthetic oligonucleotides—short strands of nucleic acids used in research, diagnostics, and increasingly, therapeutic applications. These services encompass custom synthesis of various types of oligonucleotides (e.g., antisense oligonucleotides [ASOs], small interfering RNA [siRNA], guide RNAs [gRNAs] for CRISPR applications, mRNA fragments), downstream modifications (e.g., conjugation, labeling, phosphorothioate backbones), purification, quality control (including analytical characterization), process development, scale-up, and regulatory support for Good Manufacturing Practice (GMP) compliance.
North American market for Oligonucleotide Contract Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oligonucleotide Contract Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oligonucleotide Contract Manufacturing Service in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oligonucleotide Contract Manufacturing Service include Integrated DNA Technologies, Agilent, Eurofins Genomics, Lonza, Bachem, WuXi STA, Merck, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Contract Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Contract Manufacturing Service.
The Oligonucleotide Contract Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Contract Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Contract Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Integrated DNA Technologies
Agilent
Eurofins Genomics
Lonza
Bachem
WuXi STA
Merck
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
QIAGEN
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Segment by Type
DNA Oligonucleotides
RNA Oligonucleotides
Segment by Application
Pharmaceuticals
Diagnostics
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Contract Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Oligonucleotide Contract Manufacturing provides end-to-end services for the production of synthetic oligonucleotides—short strands of nucleic acids used in research, diagnostics, and increasingly, therapeutic applications. These services encompass custom synthesis of various types of oligonucleotides (e.g., antisense oligonucleotides [ASOs], small interfering RNA [siRNA], guide RNAs [gRNAs] for CRISPR applications, mRNA fragments), downstream modifications (e.g., conjugation, labeling, phosphorothioate backbones), purification, quality control (including analytical characterization), process development, scale-up, and regulatory support for Good Manufacturing Practice (GMP) compliance.
North American market for Oligonucleotide Contract Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oligonucleotide Contract Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oligonucleotide Contract Manufacturing Service in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oligonucleotide Contract Manufacturing Service include Integrated DNA Technologies, Agilent, Eurofins Genomics, Lonza, Bachem, WuXi STA, Merck, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Contract Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Contract Manufacturing Service.
The Oligonucleotide Contract Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Contract Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Contract Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Integrated DNA Technologies
Agilent
Eurofins Genomics
Lonza
Bachem
WuXi STA
Merck
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
QIAGEN
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Segment by Type
DNA Oligonucleotides
RNA Oligonucleotides
Segment by Application
Pharmaceuticals
Diagnostics
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Contract Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA Oligonucleotides
1.2.3 RNA Oligonucleotides
1.3 Market by Application
1.3.1 Global Oligonucleotide Contract Manufacturing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Diagnostics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Contract Manufacturing Service Market Perspective (2020-2031)
2.2 Global Oligonucleotide Contract Manufacturing Service Growth Trends by Region
2.2.1 Global Oligonucleotide Contract Manufacturing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oligonucleotide Contract Manufacturing Service Historic Market Size by Region (2020-2025)
2.2.3 Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Region (2026-2031)
2.3 Oligonucleotide Contract Manufacturing Service Market Dynamics
2.3.1 Oligonucleotide Contract Manufacturing Service Industry Trends
2.3.2 Oligonucleotide Contract Manufacturing Service Market Drivers
2.3.3 Oligonucleotide Contract Manufacturing Service Market Challenges
2.3.4 Oligonucleotide Contract Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Contract Manufacturing Service Players by Revenue
3.1.1 Global Top Oligonucleotide Contract Manufacturing Service Players by Revenue (2020-2025)
3.1.2 Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Oligonucleotide Contract Manufacturing Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide Contract Manufacturing Service Revenue
3.4 Global Oligonucleotide Contract Manufacturing Service Market Concentration Ratio
3.4.1 Global Oligonucleotide Contract Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Contract Manufacturing Service Revenue in 2024
3.5 Global Key Players of Oligonucleotide Contract Manufacturing Service Head office and Area Served
3.6 Global Key Players of Oligonucleotide Contract Manufacturing Service, Product and Application
3.7 Global Key Players of Oligonucleotide Contract Manufacturing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Contract Manufacturing Service Breakdown Data by Type
4.1 Global Oligonucleotide Contract Manufacturing Service Historic Market Size by Type (2020-2025)
4.2 Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Type (2026-2031)
5 Oligonucleotide Contract Manufacturing Service Breakdown Data by Application
5.1 Global Oligonucleotide Contract Manufacturing Service Historic Market Size by Application (2020-2025)
5.2 Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
6.2 North America Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
6.4 North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
7.2 Europe Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
7.4 Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
8.2 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
9.2 Latin America Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
9.4 Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
10.2 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotide Contract Manufacturing Service Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.1.5 Integrated DNA Technologies Recent Development
11.2 Agilent
11.2.1 Agilent Company Details
11.2.2 Agilent Business Overview
11.2.3 Agilent Oligonucleotide Contract Manufacturing Service Introduction
11.2.4 Agilent Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.2.5 Agilent Recent Development
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Company Details
11.3.2 Eurofins Genomics Business Overview
11.3.3 Eurofins Genomics Oligonucleotide Contract Manufacturing Service Introduction
11.3.4 Eurofins Genomics Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.3.5 Eurofins Genomics Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Oligonucleotide Contract Manufacturing Service Introduction
11.4.4 Lonza Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.4.5 Lonza Recent Development
11.5 Bachem
11.5.1 Bachem Company Details
11.5.2 Bachem Business Overview
11.5.3 Bachem Oligonucleotide Contract Manufacturing Service Introduction
11.5.4 Bachem Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.5.5 Bachem Recent Development
11.6 WuXi STA
11.6.1 WuXi STA Company Details
11.6.2 WuXi STA Business Overview
11.6.3 WuXi STA Oligonucleotide Contract Manufacturing Service Introduction
11.6.4 WuXi STA Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.6.5 WuXi STA Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Oligonucleotide Contract Manufacturing Service Introduction
11.7.4 Merck Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.7.5 Merck Recent Development
11.8 L.G.C Biosearch Technologies
11.8.1 L.G.C Biosearch Technologies Company Details
11.8.2 L.G.C Biosearch Technologies Business Overview
11.8.3 L.G.C Biosearch Technologies Oligonucleotide Contract Manufacturing Service Introduction
11.8.4 L.G.C Biosearch Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.8.5 L.G.C Biosearch Technologies Recent Development
11.9 Eurogentec S.A
11.9.1 Eurogentec S.A Company Details
11.9.2 Eurogentec S.A Business Overview
11.9.3 Eurogentec S.A Oligonucleotide Contract Manufacturing Service Introduction
11.9.4 Eurogentec S.A Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.9.5 Eurogentec S.A Recent Development
11.10 Nitto Denko Avecia Inc
11.10.1 Nitto Denko Avecia Inc Company Details
11.10.2 Nitto Denko Avecia Inc Business Overview
11.10.3 Nitto Denko Avecia Inc Oligonucleotide Contract Manufacturing Service Introduction
11.10.4 Nitto Denko Avecia Inc Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.10.5 Nitto Denko Avecia Inc Recent Development
11.11 GenScript
11.11.1 GenScript Company Details
11.11.2 GenScript Business Overview
11.11.3 GenScript Oligonucleotide Contract Manufacturing Service Introduction
11.11.4 GenScript Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.11.5 GenScript Recent Development
11.12 BBI Life Sciences
11.12.1 BBI Life Sciences Company Details
11.12.2 BBI Life Sciences Business Overview
11.12.3 BBI Life Sciences Oligonucleotide Contract Manufacturing Service Introduction
11.12.4 BBI Life Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.12.5 BBI Life Sciences Recent Development
11.13 GeneDesign
11.13.1 GeneDesign Company Details
11.13.2 GeneDesign Business Overview
11.13.3 GeneDesign Oligonucleotide Contract Manufacturing Service Introduction
11.13.4 GeneDesign Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.13.5 GeneDesign Recent Development
11.14 TriLink BioTechnologies
11.14.1 TriLink BioTechnologies Company Details
11.14.2 TriLink BioTechnologies Business Overview
11.14.3 TriLink BioTechnologies Oligonucleotide Contract Manufacturing Service Introduction
11.14.4 TriLink BioTechnologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.14.5 TriLink BioTechnologies Recent Development
11.15 QIAGEN
11.15.1 QIAGEN Company Details
11.15.2 QIAGEN Business Overview
11.15.3 QIAGEN Oligonucleotide Contract Manufacturing Service Introduction
11.15.4 QIAGEN Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.15.5 QIAGEN Recent Development
11.16 LC Sciences
11.16.1 LC Sciences Company Details
11.16.2 LC Sciences Business Overview
11.16.3 LC Sciences Oligonucleotide Contract Manufacturing Service Introduction
11.16.4 LC Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.16.5 LC Sciences Recent Development
11.17 Twist Bioscience
11.17.1 Twist Bioscience Company Details
11.17.2 Twist Bioscience Business Overview
11.17.3 Twist Bioscience Oligonucleotide Contract Manufacturing Service Introduction
11.17.4 Twist Bioscience Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.17.5 Twist Bioscience Recent Development
11.18 Creative Biogene
11.18.1 Creative Biogene Company Details
11.18.2 Creative Biogene Business Overview
11.18.3 Creative Biogene Oligonucleotide Contract Manufacturing Service Introduction
11.18.4 Creative Biogene Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.18.5 Creative Biogene Recent Development
11.19 General Biosystems
11.19.1 General Biosystems Company Details
11.19.2 General Biosystems Business Overview
11.19.3 General Biosystems Oligonucleotide Contract Manufacturing Service Introduction
11.19.4 General Biosystems Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.19.5 General Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA Oligonucleotides
1.2.3 RNA Oligonucleotides
1.3 Market by Application
1.3.1 Global Oligonucleotide Contract Manufacturing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Diagnostics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Contract Manufacturing Service Market Perspective (2020-2031)
2.2 Global Oligonucleotide Contract Manufacturing Service Growth Trends by Region
2.2.1 Global Oligonucleotide Contract Manufacturing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oligonucleotide Contract Manufacturing Service Historic Market Size by Region (2020-2025)
2.2.3 Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Region (2026-2031)
2.3 Oligonucleotide Contract Manufacturing Service Market Dynamics
2.3.1 Oligonucleotide Contract Manufacturing Service Industry Trends
2.3.2 Oligonucleotide Contract Manufacturing Service Market Drivers
2.3.3 Oligonucleotide Contract Manufacturing Service Market Challenges
2.3.4 Oligonucleotide Contract Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Contract Manufacturing Service Players by Revenue
3.1.1 Global Top Oligonucleotide Contract Manufacturing Service Players by Revenue (2020-2025)
3.1.2 Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Oligonucleotide Contract Manufacturing Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide Contract Manufacturing Service Revenue
3.4 Global Oligonucleotide Contract Manufacturing Service Market Concentration Ratio
3.4.1 Global Oligonucleotide Contract Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Contract Manufacturing Service Revenue in 2024
3.5 Global Key Players of Oligonucleotide Contract Manufacturing Service Head office and Area Served
3.6 Global Key Players of Oligonucleotide Contract Manufacturing Service, Product and Application
3.7 Global Key Players of Oligonucleotide Contract Manufacturing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Contract Manufacturing Service Breakdown Data by Type
4.1 Global Oligonucleotide Contract Manufacturing Service Historic Market Size by Type (2020-2025)
4.2 Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Type (2026-2031)
5 Oligonucleotide Contract Manufacturing Service Breakdown Data by Application
5.1 Global Oligonucleotide Contract Manufacturing Service Historic Market Size by Application (2020-2025)
5.2 Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
6.2 North America Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
6.4 North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
7.2 Europe Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
7.4 Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
8.2 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
9.2 Latin America Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
9.4 Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size (2020-2031)
10.2 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotide Contract Manufacturing Service Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.1.5 Integrated DNA Technologies Recent Development
11.2 Agilent
11.2.1 Agilent Company Details
11.2.2 Agilent Business Overview
11.2.3 Agilent Oligonucleotide Contract Manufacturing Service Introduction
11.2.4 Agilent Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.2.5 Agilent Recent Development
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Company Details
11.3.2 Eurofins Genomics Business Overview
11.3.3 Eurofins Genomics Oligonucleotide Contract Manufacturing Service Introduction
11.3.4 Eurofins Genomics Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.3.5 Eurofins Genomics Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Oligonucleotide Contract Manufacturing Service Introduction
11.4.4 Lonza Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.4.5 Lonza Recent Development
11.5 Bachem
11.5.1 Bachem Company Details
11.5.2 Bachem Business Overview
11.5.3 Bachem Oligonucleotide Contract Manufacturing Service Introduction
11.5.4 Bachem Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.5.5 Bachem Recent Development
11.6 WuXi STA
11.6.1 WuXi STA Company Details
11.6.2 WuXi STA Business Overview
11.6.3 WuXi STA Oligonucleotide Contract Manufacturing Service Introduction
11.6.4 WuXi STA Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.6.5 WuXi STA Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Oligonucleotide Contract Manufacturing Service Introduction
11.7.4 Merck Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.7.5 Merck Recent Development
11.8 L.G.C Biosearch Technologies
11.8.1 L.G.C Biosearch Technologies Company Details
11.8.2 L.G.C Biosearch Technologies Business Overview
11.8.3 L.G.C Biosearch Technologies Oligonucleotide Contract Manufacturing Service Introduction
11.8.4 L.G.C Biosearch Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.8.5 L.G.C Biosearch Technologies Recent Development
11.9 Eurogentec S.A
11.9.1 Eurogentec S.A Company Details
11.9.2 Eurogentec S.A Business Overview
11.9.3 Eurogentec S.A Oligonucleotide Contract Manufacturing Service Introduction
11.9.4 Eurogentec S.A Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.9.5 Eurogentec S.A Recent Development
11.10 Nitto Denko Avecia Inc
11.10.1 Nitto Denko Avecia Inc Company Details
11.10.2 Nitto Denko Avecia Inc Business Overview
11.10.3 Nitto Denko Avecia Inc Oligonucleotide Contract Manufacturing Service Introduction
11.10.4 Nitto Denko Avecia Inc Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.10.5 Nitto Denko Avecia Inc Recent Development
11.11 GenScript
11.11.1 GenScript Company Details
11.11.2 GenScript Business Overview
11.11.3 GenScript Oligonucleotide Contract Manufacturing Service Introduction
11.11.4 GenScript Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.11.5 GenScript Recent Development
11.12 BBI Life Sciences
11.12.1 BBI Life Sciences Company Details
11.12.2 BBI Life Sciences Business Overview
11.12.3 BBI Life Sciences Oligonucleotide Contract Manufacturing Service Introduction
11.12.4 BBI Life Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.12.5 BBI Life Sciences Recent Development
11.13 GeneDesign
11.13.1 GeneDesign Company Details
11.13.2 GeneDesign Business Overview
11.13.3 GeneDesign Oligonucleotide Contract Manufacturing Service Introduction
11.13.4 GeneDesign Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.13.5 GeneDesign Recent Development
11.14 TriLink BioTechnologies
11.14.1 TriLink BioTechnologies Company Details
11.14.2 TriLink BioTechnologies Business Overview
11.14.3 TriLink BioTechnologies Oligonucleotide Contract Manufacturing Service Introduction
11.14.4 TriLink BioTechnologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.14.5 TriLink BioTechnologies Recent Development
11.15 QIAGEN
11.15.1 QIAGEN Company Details
11.15.2 QIAGEN Business Overview
11.15.3 QIAGEN Oligonucleotide Contract Manufacturing Service Introduction
11.15.4 QIAGEN Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.15.5 QIAGEN Recent Development
11.16 LC Sciences
11.16.1 LC Sciences Company Details
11.16.2 LC Sciences Business Overview
11.16.3 LC Sciences Oligonucleotide Contract Manufacturing Service Introduction
11.16.4 LC Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.16.5 LC Sciences Recent Development
11.17 Twist Bioscience
11.17.1 Twist Bioscience Company Details
11.17.2 Twist Bioscience Business Overview
11.17.3 Twist Bioscience Oligonucleotide Contract Manufacturing Service Introduction
11.17.4 Twist Bioscience Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.17.5 Twist Bioscience Recent Development
11.18 Creative Biogene
11.18.1 Creative Biogene Company Details
11.18.2 Creative Biogene Business Overview
11.18.3 Creative Biogene Oligonucleotide Contract Manufacturing Service Introduction
11.18.4 Creative Biogene Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.18.5 Creative Biogene Recent Development
11.19 General Biosystems
11.19.1 General Biosystems Company Details
11.19.2 General Biosystems Business Overview
11.19.3 General Biosystems Oligonucleotide Contract Manufacturing Service Introduction
11.19.4 General Biosystems Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
11.19.5 General Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of DNA Oligonucleotides
Table 3. Key Players of RNA Oligonucleotides
Table 4. Global Oligonucleotide Contract Manufacturing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oligonucleotide Contract Manufacturing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotide Contract Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oligonucleotide Contract Manufacturing Service Market Share by Region (2020-2025)
Table 8. Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oligonucleotide Contract Manufacturing Service Market Share by Region (2026-2031)
Table 10. Oligonucleotide Contract Manufacturing Service Market Trends
Table 11. Oligonucleotide Contract Manufacturing Service Market Drivers
Table 12. Oligonucleotide Contract Manufacturing Service Market Challenges
Table 13. Oligonucleotide Contract Manufacturing Service Market Restraints
Table 14. Global Oligonucleotide Contract Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oligonucleotide Contract Manufacturing Service Market Share by Players (2020-2025)
Table 16. Global Top Oligonucleotide Contract Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Contract Manufacturing Service as of 2024)
Table 17. Ranking of Global Top Oligonucleotide Contract Manufacturing Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oligonucleotide Contract Manufacturing Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oligonucleotide Contract Manufacturing Service, Headquarters and Area Served
Table 20. Global Key Players of Oligonucleotide Contract Manufacturing Service, Product and Application
Table 21. Global Key Players of Oligonucleotide Contract Manufacturing Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotide Contract Manufacturing Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Type (2020-2025)
Table 25. Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Type (2026-2031)
Table 27. Global Oligonucleotide Contract Manufacturing Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Application (2020-2025)
Table 29. Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Application (2026-2031)
Table 31. North America Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Integrated DNA Technologies Company Details
Table 47. Integrated DNA Technologies Business Overview
Table 48. Integrated DNA Technologies Oligonucleotide Contract Manufacturing Service Product
Table 49. Integrated DNA Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 50. Integrated DNA Technologies Recent Development
Table 51. Agilent Company Details
Table 52. Agilent Business Overview
Table 53. Agilent Oligonucleotide Contract Manufacturing Service Product
Table 54. Agilent Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 55. Agilent Recent Development
Table 56. Eurofins Genomics Company Details
Table 57. Eurofins Genomics Business Overview
Table 58. Eurofins Genomics Oligonucleotide Contract Manufacturing Service Product
Table 59. Eurofins Genomics Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 60. Eurofins Genomics Recent Development
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Oligonucleotide Contract Manufacturing Service Product
Table 64. Lonza Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Bachem Company Details
Table 67. Bachem Business Overview
Table 68. Bachem Oligonucleotide Contract Manufacturing Service Product
Table 69. Bachem Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 70. Bachem Recent Development
Table 71. WuXi STA Company Details
Table 72. WuXi STA Business Overview
Table 73. WuXi STA Oligonucleotide Contract Manufacturing Service Product
Table 74. WuXi STA Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 75. WuXi STA Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Oligonucleotide Contract Manufacturing Service Product
Table 79. Merck Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 80. Merck Recent Development
Table 81. L.G.C Biosearch Technologies Company Details
Table 82. L.G.C Biosearch Technologies Business Overview
Table 83. L.G.C Biosearch Technologies Oligonucleotide Contract Manufacturing Service Product
Table 84. L.G.C Biosearch Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 85. L.G.C Biosearch Technologies Recent Development
Table 86. Eurogentec S.A Company Details
Table 87. Eurogentec S.A Business Overview
Table 88. Eurogentec S.A Oligonucleotide Contract Manufacturing Service Product
Table 89. Eurogentec S.A Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 90. Eurogentec S.A Recent Development
Table 91. Nitto Denko Avecia Inc Company Details
Table 92. Nitto Denko Avecia Inc Business Overview
Table 93. Nitto Denko Avecia Inc Oligonucleotide Contract Manufacturing Service Product
Table 94. Nitto Denko Avecia Inc Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 95. Nitto Denko Avecia Inc Recent Development
Table 96. GenScript Company Details
Table 97. GenScript Business Overview
Table 98. GenScript Oligonucleotide Contract Manufacturing Service Product
Table 99. GenScript Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 100. GenScript Recent Development
Table 101. BBI Life Sciences Company Details
Table 102. BBI Life Sciences Business Overview
Table 103. BBI Life Sciences Oligonucleotide Contract Manufacturing Service Product
Table 104. BBI Life Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 105. BBI Life Sciences Recent Development
Table 106. GeneDesign Company Details
Table 107. GeneDesign Business Overview
Table 108. GeneDesign Oligonucleotide Contract Manufacturing Service Product
Table 109. GeneDesign Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 110. GeneDesign Recent Development
Table 111. TriLink BioTechnologies Company Details
Table 112. TriLink BioTechnologies Business Overview
Table 113. TriLink BioTechnologies Oligonucleotide Contract Manufacturing Service Product
Table 114. TriLink BioTechnologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 115. TriLink BioTechnologies Recent Development
Table 116. QIAGEN Company Details
Table 117. QIAGEN Business Overview
Table 118. QIAGEN Oligonucleotide Contract Manufacturing Service Product
Table 119. QIAGEN Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 120. QIAGEN Recent Development
Table 121. LC Sciences Company Details
Table 122. LC Sciences Business Overview
Table 123. LC Sciences Oligonucleotide Contract Manufacturing Service Product
Table 124. LC Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 125. LC Sciences Recent Development
Table 126. Twist Bioscience Company Details
Table 127. Twist Bioscience Business Overview
Table 128. Twist Bioscience Oligonucleotide Contract Manufacturing Service Product
Table 129. Twist Bioscience Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 130. Twist Bioscience Recent Development
Table 131. Creative Biogene Company Details
Table 132. Creative Biogene Business Overview
Table 133. Creative Biogene Oligonucleotide Contract Manufacturing Service Product
Table 134. Creative Biogene Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 135. Creative Biogene Recent Development
Table 136. General Biosystems Company Details
Table 137. General Biosystems Business Overview
Table 138. General Biosystems Oligonucleotide Contract Manufacturing Service Product
Table 139. General Biosystems Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 140. General Biosystems Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. Oligonucleotide Contract Manufacturing Service Picture
Figure 2. Global Oligonucleotide Contract Manufacturing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide Contract Manufacturing Service Market Share by Type: 2024 VS 2031
Figure 4. DNA Oligonucleotides Features
Figure 5. RNA Oligonucleotides Features
Figure 6. Global Oligonucleotide Contract Manufacturing Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oligonucleotide Contract Manufacturing Service Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Diagnostics Case Studies
Figure 10. Others Case Studies
Figure 11. Oligonucleotide Contract Manufacturing Service Report Years Considered
Figure 12. Global Oligonucleotide Contract Manufacturing Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oligonucleotide Contract Manufacturing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oligonucleotide Contract Manufacturing Service Market Share by Region: 2024 VS 2031
Figure 15. Global Oligonucleotide Contract Manufacturing Service Market Share by Players in 2024
Figure 16. Global Oligonucleotide Contract Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotide Contract Manufacturing Service Revenue in 2024
Figure 18. North America Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 20. United States Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 24. Germany Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Ireland Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Share by Region (2020-2031)
Figure 32. China Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia & New Zealand Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 40. Mexico Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 44. Israel Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 48. Agilent Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 49. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 50. Lonza Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 51. Bachem Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 52. WuXi STA Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 54. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 55. Eurogentec S.A Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 56. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 57. GenScript Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 58. BBI Life Sciences Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 59. GeneDesign Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 60. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 61. QIAGEN Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 62. LC Sciences Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 63. Twist Bioscience Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 64. Creative Biogene Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 65. General Biosystems Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of DNA Oligonucleotides
Table 3. Key Players of RNA Oligonucleotides
Table 4. Global Oligonucleotide Contract Manufacturing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oligonucleotide Contract Manufacturing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotide Contract Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oligonucleotide Contract Manufacturing Service Market Share by Region (2020-2025)
Table 8. Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oligonucleotide Contract Manufacturing Service Market Share by Region (2026-2031)
Table 10. Oligonucleotide Contract Manufacturing Service Market Trends
Table 11. Oligonucleotide Contract Manufacturing Service Market Drivers
Table 12. Oligonucleotide Contract Manufacturing Service Market Challenges
Table 13. Oligonucleotide Contract Manufacturing Service Market Restraints
Table 14. Global Oligonucleotide Contract Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oligonucleotide Contract Manufacturing Service Market Share by Players (2020-2025)
Table 16. Global Top Oligonucleotide Contract Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Contract Manufacturing Service as of 2024)
Table 17. Ranking of Global Top Oligonucleotide Contract Manufacturing Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oligonucleotide Contract Manufacturing Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oligonucleotide Contract Manufacturing Service, Headquarters and Area Served
Table 20. Global Key Players of Oligonucleotide Contract Manufacturing Service, Product and Application
Table 21. Global Key Players of Oligonucleotide Contract Manufacturing Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotide Contract Manufacturing Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Type (2020-2025)
Table 25. Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Type (2026-2031)
Table 27. Global Oligonucleotide Contract Manufacturing Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Application (2020-2025)
Table 29. Global Oligonucleotide Contract Manufacturing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oligonucleotide Contract Manufacturing Service Revenue Market Share by Application (2026-2031)
Table 31. North America Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Integrated DNA Technologies Company Details
Table 47. Integrated DNA Technologies Business Overview
Table 48. Integrated DNA Technologies Oligonucleotide Contract Manufacturing Service Product
Table 49. Integrated DNA Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 50. Integrated DNA Technologies Recent Development
Table 51. Agilent Company Details
Table 52. Agilent Business Overview
Table 53. Agilent Oligonucleotide Contract Manufacturing Service Product
Table 54. Agilent Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 55. Agilent Recent Development
Table 56. Eurofins Genomics Company Details
Table 57. Eurofins Genomics Business Overview
Table 58. Eurofins Genomics Oligonucleotide Contract Manufacturing Service Product
Table 59. Eurofins Genomics Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 60. Eurofins Genomics Recent Development
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Oligonucleotide Contract Manufacturing Service Product
Table 64. Lonza Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Bachem Company Details
Table 67. Bachem Business Overview
Table 68. Bachem Oligonucleotide Contract Manufacturing Service Product
Table 69. Bachem Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 70. Bachem Recent Development
Table 71. WuXi STA Company Details
Table 72. WuXi STA Business Overview
Table 73. WuXi STA Oligonucleotide Contract Manufacturing Service Product
Table 74. WuXi STA Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 75. WuXi STA Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Oligonucleotide Contract Manufacturing Service Product
Table 79. Merck Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 80. Merck Recent Development
Table 81. L.G.C Biosearch Technologies Company Details
Table 82. L.G.C Biosearch Technologies Business Overview
Table 83. L.G.C Biosearch Technologies Oligonucleotide Contract Manufacturing Service Product
Table 84. L.G.C Biosearch Technologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 85. L.G.C Biosearch Technologies Recent Development
Table 86. Eurogentec S.A Company Details
Table 87. Eurogentec S.A Business Overview
Table 88. Eurogentec S.A Oligonucleotide Contract Manufacturing Service Product
Table 89. Eurogentec S.A Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 90. Eurogentec S.A Recent Development
Table 91. Nitto Denko Avecia Inc Company Details
Table 92. Nitto Denko Avecia Inc Business Overview
Table 93. Nitto Denko Avecia Inc Oligonucleotide Contract Manufacturing Service Product
Table 94. Nitto Denko Avecia Inc Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 95. Nitto Denko Avecia Inc Recent Development
Table 96. GenScript Company Details
Table 97. GenScript Business Overview
Table 98. GenScript Oligonucleotide Contract Manufacturing Service Product
Table 99. GenScript Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 100. GenScript Recent Development
Table 101. BBI Life Sciences Company Details
Table 102. BBI Life Sciences Business Overview
Table 103. BBI Life Sciences Oligonucleotide Contract Manufacturing Service Product
Table 104. BBI Life Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 105. BBI Life Sciences Recent Development
Table 106. GeneDesign Company Details
Table 107. GeneDesign Business Overview
Table 108. GeneDesign Oligonucleotide Contract Manufacturing Service Product
Table 109. GeneDesign Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 110. GeneDesign Recent Development
Table 111. TriLink BioTechnologies Company Details
Table 112. TriLink BioTechnologies Business Overview
Table 113. TriLink BioTechnologies Oligonucleotide Contract Manufacturing Service Product
Table 114. TriLink BioTechnologies Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 115. TriLink BioTechnologies Recent Development
Table 116. QIAGEN Company Details
Table 117. QIAGEN Business Overview
Table 118. QIAGEN Oligonucleotide Contract Manufacturing Service Product
Table 119. QIAGEN Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 120. QIAGEN Recent Development
Table 121. LC Sciences Company Details
Table 122. LC Sciences Business Overview
Table 123. LC Sciences Oligonucleotide Contract Manufacturing Service Product
Table 124. LC Sciences Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 125. LC Sciences Recent Development
Table 126. Twist Bioscience Company Details
Table 127. Twist Bioscience Business Overview
Table 128. Twist Bioscience Oligonucleotide Contract Manufacturing Service Product
Table 129. Twist Bioscience Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 130. Twist Bioscience Recent Development
Table 131. Creative Biogene Company Details
Table 132. Creative Biogene Business Overview
Table 133. Creative Biogene Oligonucleotide Contract Manufacturing Service Product
Table 134. Creative Biogene Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 135. Creative Biogene Recent Development
Table 136. General Biosystems Company Details
Table 137. General Biosystems Business Overview
Table 138. General Biosystems Oligonucleotide Contract Manufacturing Service Product
Table 139. General Biosystems Revenue in Oligonucleotide Contract Manufacturing Service Business (2020-2025) & (US$ Million)
Table 140. General Biosystems Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. Oligonucleotide Contract Manufacturing Service Picture
Figure 2. Global Oligonucleotide Contract Manufacturing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide Contract Manufacturing Service Market Share by Type: 2024 VS 2031
Figure 4. DNA Oligonucleotides Features
Figure 5. RNA Oligonucleotides Features
Figure 6. Global Oligonucleotide Contract Manufacturing Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oligonucleotide Contract Manufacturing Service Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Diagnostics Case Studies
Figure 10. Others Case Studies
Figure 11. Oligonucleotide Contract Manufacturing Service Report Years Considered
Figure 12. Global Oligonucleotide Contract Manufacturing Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oligonucleotide Contract Manufacturing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oligonucleotide Contract Manufacturing Service Market Share by Region: 2024 VS 2031
Figure 15. Global Oligonucleotide Contract Manufacturing Service Market Share by Players in 2024
Figure 16. Global Oligonucleotide Contract Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotide Contract Manufacturing Service Revenue in 2024
Figure 18. North America Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 20. United States Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 24. Germany Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Ireland Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oligonucleotide Contract Manufacturing Service Market Share by Region (2020-2031)
Figure 32. China Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia & New Zealand Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 40. Mexico Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oligonucleotide Contract Manufacturing Service Market Share by Country (2020-2031)
Figure 44. Israel Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oligonucleotide Contract Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 48. Agilent Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 49. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 50. Lonza Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 51. Bachem Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 52. WuXi STA Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 54. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 55. Eurogentec S.A Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 56. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 57. GenScript Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 58. BBI Life Sciences Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 59. GeneDesign Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 60. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 61. QIAGEN Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 62. LC Sciences Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 63. Twist Bioscience Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 64. Creative Biogene Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 65. General Biosystems Revenue Growth Rate in Oligonucleotide Contract Manufacturing Service Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232